Platelets and vascular integrity

References

• Jackson SP. Arterial thrombosis–insidious, unpredictable and deadly. Nat Med. 2011;17:1423–1436. doi:10.1038/nm.2515.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? J Physiol. 2011;589:4115–4123. doi:10.1113/jphysiol.2011.212886.
   PubMed Web of Science ®Google Scholar
• Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61–67. doi:10.1038/nm810.
   PubMed Web of Science ®Google Scholar
• Deppermann C, Kubes P. Platelets and infection. Semin Immunol. 2016;28:536–545. doi:10.1016/j.smim.2016.10.005.
   PubMed Web of Science ®Google Scholar
• Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol. 2008;28:403–412. doi:10.1161/ATVBAHA.107.150474.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fässler R. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. Embo J. 2001;20:2120–2130. doi:10.1093/emboj/20.9.2120.
   PubMed Web of Science ®Google Scholar
• Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006;99:1293–1304. doi:10.1161/01.RES.0000251742.71301.16.
   PubMed Web of Science ®Google Scholar
• Gardiner E.E., Al-Tamimi M., Andrews R.K., Berndt M.C. Platelet Receptor Shedding. In: Gibbins J., Mahaut-Smith M., editors. Platelets and Megakaryocytes. Methods in Molecular Biology (Methods and Protocols). vol 788. Springer, New York, NY; 2012
   Google Scholar
• Blair P, Flaumenhaft R. Platelet α-granules: basic biology and clinical correlates. Blood Rev. 2009;23:177–189. doi:10.1016/j.blre.2009.04.001.Platelet.
   PubMed Web of Science ®Google Scholar
• Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97–119.
   PubMed Web of Science ®Google Scholar
• Nurden A, Freson K, Seligsohn U. Inherited platelet disorders. Haemophilia. 2012;18(Suppl 4):154–160. doi:10.1111/j.1365-2516.2012.02856.x.
   PubMed Web of Science ®Google Scholar
• Watson SP, Auger JM, McCarty OJT, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost. 2005;3:1752–1762. doi:10.1111/j.1538-7836.2005.01429.x.
   PubMed Web of Science ®Google Scholar
• Bennett JS. Structure and function of the platelet integrin αIIbβ3. J Clin Invest. 2005;115:3363–3369. doi:10.1172/JCI26989.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P. Congenital platelet disorders and understanding of platelet function. Br J Haematol. 2014;165:165–178. doi:10.1111/bjh.12662.
   PubMed Web of Science ®Google Scholar
• Lax S, Rayes J, Wichaiyo S, Haining EJ, Lowe K, Grygielska B, Laloo R, Flodby P, Borok Z, Crandall ED, Thickett D, Watson SP. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Am J Physiol Lung Cell Mol Physiol. 2017;44. ajplung.00023.2017. doi:10.1152/ajplung.00023.2017.
   Google Scholar
• Watson SP, Herbert JMJ, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost. 2010;8:1456–1467. doi:10.1111/j.1538-7836.2010.03875.x.
   PubMed Web of Science ®Google Scholar
• Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, Sebzda E, Santore MT, Merianos DJ, Stadtfeld M, Flake AW, Graf T, Skoda R, Maltzman JS, Koretzky GA, Kahn ML. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 2010;116:661–670. doi:10.1182/blood-2010-02-270876.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001;193:459–469. doi:10.1084/jem.193.4.459.
   PubMed Web of Science ®Google Scholar
• May F, Hagedorn I, Pleines I, Bender M, Vogtle T, Eble J, Elvers M, Nieswandt B. CLEC-2 is an essential platelet activating receptor in hemostasis and thrombosis. Blood. 2009;114:3464–3473. doi:10.1182/blood-2009-05-222273.An.
   PubMed Web of Science ®Google Scholar
• Danielli JF. Capillary permeability and oedema in the perfused frog. J Physiol. 1940;98:109–129. doi:10.1113/jphysiol.1940.sp003837.
   PubMedGoogle Scholar
• Gimbrone MA, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature. 1969;222:33–36. doi:10.1038/222033a0.
   PubMed Web of Science ®Google Scholar
• Roy AJ, Djerassi I. Effects of platelet transfusions: plug formation and maintenance of vascular integrity. Exp Biol Med. 1972;139:137–142. doi:10.3181/00379727-139-36096.
   Web of Science ®Google Scholar
• Aursnes I. Increased permeability of capillaries to protein during thrombocytopenia an experimental study in the rabbit. Microvasc Res. 1974;7:283–295. doi:10.1016/0026-2862(74)90016-8.
   PubMed Web of Science ®Google Scholar
• Kitchens C, Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood. 1975;46:567–578.
   PubMed Web of Science ®Google Scholar
• Saba SR, Mason RG. Effects of platelets and certain platelet components on growth of cultured human endothelial cells. Thromb Res. 1975;7:807–812. doi:10.1016/0049-3848(75)90205-4.
   PubMed Web of Science ®Google Scholar
• Haselton FR, Alexander JS. Platelets and a platelet-released factor enhance endothelial barrier. Am J Physiol. 1992;263:L670–L678.
   PubMed Web of Science ®Google Scholar
• Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999;22:11–28. doi:10.1146/annurev.neuro.22.1.11.
   PubMed Web of Science ®Google Scholar
• Finney BA, Schweighoffer E, Navarro-Núñez L, Bénézech C, Barone F, Hughes CE, Langan SA, Lowe KL, Pollitt AY, Mourao-Sa D, Sheardown S, Nash GB, Smithers N, Reis C, Sousa E, Tybulewicz VLJ, Watson SP. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood. 2012;119:1747–1756. doi:10.1182/blood-2011-09-380709.
   PubMed Web of Science ®Google Scholar
• Lowe KL, Finney BA, Deppermann C, Hagerling R, Gazit SL, Frampton J, Buckley CD, Camerer E, Nieswandt B, Kiefer F, Watson SP. Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. Blood. 2015;125:3769–3777. doi:10.1182/blood-2014-09-603803.
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009;23:177–189. doi:10.1016/j.blre.2009.04.001.
   PubMed Web of Science ®Google Scholar
• Golebiewska EM, Poole AW. Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev. 2015;29:153–162. doi:10.1016/j.blre.2014.10.003.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007;21:99–111. doi:10.1016/j.blre.2006.06.001.
   PubMed Web of Science ®Google Scholar
• Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129:2829–2835. doi:10.1182/blood-2017-03-754119.
   PubMed Web of Science ®Google Scholar
• Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160:1630–1638. doi:10.1001/archinte.160.11.1630.
   PubMed Web of Science ®Google Scholar
• Neunert C, Buchanan GR, Imbach PA, Bolton-Maggs PHB, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kuehne T. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia (ITP): data from the intercontinental cooperative ITP study group. Blood. 2009;114:4457–4463. doi:10.1182/blood-2012-12-466375.The.
   Web of Science ®Google Scholar
• Arnold DM. Platelet count or bleeding as the outcome in ITP trials. Am J Hematol. 2012;87:945–946. doi:10.1002/ajh.23299.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood. 2000;96:2520–2527.
   PubMed Web of Science ®Google Scholar
• Goerge T, Ho-Tin-Noe B, Carbo C, Benarafa C, Remold-O’Donnell E, Zhao BQ, Cifuni SM, Wagner DD. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111:4958–4964. doi:10.1182/blood-2007-11-123620.
   PubMed Web of Science ®Google Scholar
• Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, Mackman N, Owens AP, Ware J, Kahn ML, Bergmeier W. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123:908–916. doi:10.1172/JCI65154.
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noé B, Goerge T, Cifuni SMS, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008;68:6851–6858. doi:10.1158/0008-5472.CAN-08-0718.
   PubMed Web of Science ®Google Scholar
• Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102:1701–1707. doi:10.1182/blood-2003-03-0717.
   PubMed Web of Science ®Google Scholar
• Rayes J, Jadoui S, Lax S, Gros A, Wichaiyo S, Ollivier V, Denis CV, Ware J, Nieswandt B, Jandrot-Perrus M, Watson SP, Ho-Tin-Noé B. The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent. 2017. Published ahead of print in Haematologica 2018 (doi:10.3324/haematol.2017.182162).
   Google Scholar
• Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115:2323–2330. doi:10.1161/CIRCULATIONAHA.107.691279.
   PubMed Web of Science ®Google Scholar
• Boulaftali Y, Hess PR, Kahn ML, Bergmeier W. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res. 2014;114:1174–1184. doi:10.1161/CIRCRESAHA.114.301611.
   PubMed Web of Science ®Google Scholar
• Gros A, Syvannarath V, Lamrani L, Ollivier V, Loyau S, Goerge T, Nieswandt B, Jandrot-Perrus M, Ho-Tin-Noé B. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex – mediated inflammation in mice. Blood. 2015;126:1017–1027. doi:10.1182/blood-2014-12-617159.The.
   PubMed Web of Science ®Google Scholar
• Stegner D, Deppermann C, Kraft P, Morowski M, Kleinschnitz C, Stoll G, Nieswandt B. Munc13-4 mediated secretion is essential for infarct progression but not intracranial haemostasis in acute stroke. J Thromb Haemost. 2013;11:1430–1433. doi:10.1111/jth.12293.
   PubMed Web of Science ®Google Scholar
• Deppermann C, Cherpokova D, Nurden P, Schulz J-N, Thielmann I, Kraft P, Vögtle T, Kleinschnitz C, Dütting S, Krohne G, Eming SA, Nurden AT, Eckes B, Stoll G, Stegner D, Nieswandt B. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest. 2013;123:3331–3342. doi:10.1172/JCI69210.the.
   Web of Science ®Google Scholar
• King SM, Reed GL. Development of platelet secretory granules, Semin. Cell Dev Biol. 2002;13:293–302. doi:10.1016/S1084.
   Google Scholar
• Ren Q, Wimmer C, Chicka MC, Ye S, Ren Y, Hughson FM, Whiteheart SW. Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis. Blood. 2010;116:869–877. doi:10.1182/blood-2010-02-270934.
   PubMed Web of Science ®Google Scholar
• Savage JS, Williams CM, Konopatskaya O, Hers I, Harper MT, Poole AW. Munc13-4 is critical for thrombosis through regulating release of ADP from platelets. J Thromb Haemost. 2013;11:771–775. doi:10.1111/jth.12138.
   PubMed Web of Science ®Google Scholar
• Deppermann C, Nurden P, Nurden AT, Nieswandt B, Stegner D. The Nbeal2-/- mouse as a model for the gray platelet syndrome. Rare Dis. 2013;1:e26561. doi:10.4161/rdis.26561.
   PubMedGoogle Scholar
• Kahr WHA, Lo RW, Li L, Pluthero FG, Christensen H, Ni R, Vaezzadeh N, Hawkins CE, Weyrich AS, Di Paola J, Landolt-Marticorena C, Gross PL. Abnormal megakaryocyte development and platelet function in Nbeal2-/- mice. Blood. 2013;122:3349–3358. doi:10.1182/blood-2013-04-499491.
   PubMed Web of Science ®Google Scholar
• Guerrero JA, Bennett C, Van Der Weyden L, McKinney H, Chin M, Nurden P, McIntyre Z, Cambridge EL, Estabel J, Wardle-Jones H, Speak AO, Erber WN, Rendon A, Ouwehand WH, Ghevaert C. Gray platelet syndrome: pro-inflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer resistance to cancer metastasis in mice. Blood. 2014;124:3624–3635. doi:10.1182/blood-2014-04-566760.
   PubMed Web of Science ®Google Scholar
• Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell. 2013;24:1–8. doi:10.1016/j.ccr.2013.05.008.
   PubMed Web of Science ®Google Scholar
• Deppermann C, Kraft P, Volz J, Schuhmann MK, Beck S, Wolf K, Stegner D, Stoll G, Nieswandt B. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice. Blood. 2017;129:1702–1707. doi:10.1182/blood-2016-12-750711.
   PubMed Web of Science ®Google Scholar
• Higgins SJ, Purcell LA, Silver KL, Tran V, Crowley V, Hawkes M, Conroy AL, Opoka RO, Hay JG, Quaggin SE, Thurston G, Liles WC, Kain KC. Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria. Sci Transl Med. 2016;8:358ra128. doi:10.1126/scitranslmed.aaf6812.
   PubMed Web of Science ®Google Scholar
• Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131–147. doi:10.1023/A:1007074420772.
   PubMed Web of Science ®Google Scholar
• Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692–704. doi:10.1038/nri3908.
   PubMed Web of Science ®Google Scholar
• Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678–689. doi:10.1038/nri2156.
   PubMed Web of Science ®Google Scholar
• Cochrane CG, Aikin BS. Polymorphonuclear leukocytes in immunologic reactions. J Exp Med. 1966;124:733–752.
   PubMed Web of Science ®Google Scholar
• Hillgruber C, Poppelmann B, Weishaupt C, Steingraber AK, Wessel F, Berdel WE, Gessner JE, Ho-Tin-Noe B, Vestweber D, Goerge T. Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia. J Exp Med. 2015. doi:10.1084/jem.20142076.
   PubMed Web of Science ®Google Scholar
• Verhenne S, Denorme F, Libbrecht S, Vandenbulcke A, Pareyn I, Deckmyn H, Lambrecht A, Nieswandt B, Kleinschnitz C, Vanhoorelbeke K, De Meyer SF. While not essential for normal thrombosis and hemostasis, platelet-derived VWF fosters ischemic stroke injury in mice. Blood. 2015;32. doi:10.1182/blood-2015-03-632901.
   Google Scholar
• De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C. Thromboinflammation in stroke brain damage. Stroke. 2016;47:1165–1172. doi:10.1161/STROKEAHA.115.011238.
   PubMed Web of Science ®Google Scholar